# Treatment of Patients With COVID-19 With Convalescent Plasma

> **NCT04415086** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 129 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** convalescent plasma

## Key facts

- **NCT ID:** NCT04415086
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-02-15
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04415086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04415086, "Treatment of Patients With COVID-19 With Convalescent Plasma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04415086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*